July 26, 2021
Ascendia Pharma Chief Business Officer Robert Bloder will be a speaker on a contract development and manufacturing organization (CDMO) panel […]
READ MORE >
Sophisticated formulations in every stage of development from MOLECULE to FORMULATION to CLINICAL 
Our Technologies
EMULSOL
AMORSOL
NANOSOL
A wide array of pharmaceutical development capabilities for manufacturing and
analyzing drug product dosage forms. READ MORE >
FEATURED
Ascendia Pharma to Highlight How to Make Insoluble Soluble During CPhI North America
Ascendia Pharma is attending CPhI North America in Philadelphia, from August 10-12. In its booth (#1508), the leading specialty pharmaceutical […]
READ MOREPARTNERING WITH ASCENDIA
Ascendia provides its partners rapid, comprehensive and cost-effective
solutions for their difficult formulation development projects. LEARN MORE >
ASCENDIA NEWSROOM
July 20, 2021
Ascendia Pharma is attending CPhI North America in Philadelphia, from August 10-12. In its booth (#1508), the leading specialty pharmaceutical […]
READ MORE >July 12, 2021
As the number of therapeutic molecules in development has more than doubled – from about 6,000 to in excess of […]
READ MORE >